微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.38% | -15% | -67.08% | 44/158 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 7.23% | -12.04% | 7.59% | 46/158 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 6.72% | -4.82% | 66.34% | 53/158 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 4.04% | -14.04% | 44.29% | 50/158 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.8% | -2.78% | -65.94% | 40/158 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 8.22% | 28.44% | 16.43% | 39/158 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 7.06% | 25.62% | 50.21% | 46/158 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 4.7% | 40.72% | 63.19% | 45/158 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.88% | 51.58% | -55% | 37/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 6.4% | 5.79% | 13.88% | 60/158 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 5.62% | -3.93% | 68.26% | 58/158 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 3.34% | -3.75% | 75.79% | 63/158 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.9% | -15.18% | -68.6% | 61/158 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 6.05% | -29.73% | 3.42% | 69/158 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 5.85% | -14.85% | 68.59% | 67/158 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 3.47% | -1.14% | 54.91% | 74/158 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.24% | -2.18% | -73.98% | 63/158 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 8.61% | -21.01% | 25.33% | 66/158 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 6.87% | -27.22% | 95.73% | 58/158 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 3.51% | -36.18% | 53.28% | 70/158 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 2.29% | -24.42% | -78.99% | 44/158 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 10.9% | -9.92% | 15.47% | 54/158 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 9.44% | -1.56% | 71.64% | 38/158 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 5.5% | -7.09% | 81.52% | 41/158 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.03% | -4.42% | -74.96% | 36/158 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 12.1% | -0.17% | 26.17% | 39/158 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 9.59% | 11.12% | 61.99% | 25/158 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 5.92% | 19.84% | 86.75% | 30/158 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.17% | 2% | -73.84% | 28/158 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 12.12% | 15.32% | 40.44% | 36/158 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 8.63% | 2% | 74.7% | 37/158 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.94% | -14.68% | -53% | 42/158 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 10.51% | -10.63% | -10.63% | 52/158 | 6.19% | 河化股份 | 54.24% | 行业排名> |
| 2015-12-31 | 11.76% | 4.07% | 103.11% | 44/158 | 11.27% | 华东医药 | 7.2% | 行业排名> |
| 2015-06-30 | 5.79% | 2% | -48.76% | 30/158 | 4.87% | 南新制药 | 81.7% | 行业排名> |